Skip to main content
African Journal of Primary Health Care & Family Medicine logoLink to African Journal of Primary Health Care & Family Medicine
. 2024 Feb 15;16(1):3631. doi: 10.4102/phcfm.v16i1.3631

Knowledge and practices of sickle cell disease among healthcare providers in Kinshasa, Democratic Republic of the Congo

Ange-Christian M Ngonde 1,2, Jean-Pierre L Fina 2, Edu Burgueno 3,4, Phillippe N Lukanu 3,
PMCID: PMC10913164  PMID: 38426772

Abstract

Background

In Kinshasa, Democratic Republic of Congo, there is a low evocation of the diagnosis of sickle cell disease (SCD) by first-level healthcare providers (HCPs), most likely because of poor knowledge of the disease.

Aim

To assess the levels of knowledge and practices of SCD and to identify determinants of the practices among primary HCPs.

Setting

Healthcare facilities in Selembao health zone in Kinshasa, Democratic Republic of the Congo.

Methods

A cross-sectional study of HCPs randomly selected through a two-stage sampling design. Data were collected using a pre-tested interviewer-administered questionnaire. Univariate and bivariate analysis were done to describe the levels of knowledge and practices of SCD. Factors associated with better practices on SCD were determined using multiple linear regression. The threshold for statistical significance was p ˂ 0.05.

Results

A total of 318 HCPs, which included 80 physicians and 238 nurses, participated in the study. The participants showed different scores on the components of the knowledge. All the participants showed poor practices on SCD. Multiple linear regression retained overall knowledge of SCD as a significant predictor of better practice for physicians. Knowledge of SCD and duration of work experience were significant predictors of better practices among nurses.

Conclusion

The practices of healthcare providers on SCD were far from optimal. These practices were significantly associated with knowledge and experience of healthcare providers.

Contribution

This study highlighted the need for continuing professional education to enhance the management of SCD in the setting.

Keywords: sickle cell disease, healthcare providers, knowledge, practices, primary health care

Introduction

Sickle cell disease (SCD) is a common genetic disease, the sickle cell trait variant affecting about 300 million people worldwide, with one-third of the cases in sub-Saharan Africa, while the prevalence rates in the United States is 9% among African American people and 0.2% among Caucasian people.1 In some areas of sub-Saharan Africa, up to 2% of all children are born with the condition. In broad terms, the prevalence of the sickle-cell trait (healthy carriers who have inherited the mutant gene from only one parent) ranges between 10% and 40% across equatorial Africa and decreases to between 1% and 2% on the north African coast and <1% in Southern Africa.2 The disease usually presents between the ages of 6 and 18 months with homozygous carriers of the sickle cell gene having a shortened life expectancy because of multiple complications. The survival of SCD patients depends on the quality of the healthcare systems.2 In high-income countries, the median survival of SCD patients is more than 60 years, and childhood mortality is now close to that in the general population. In the lower-income countries of Africa with poor healthcare systems, the under-five mortality of SCD can be as high as 90%.3,4

In 2010, the World Health Organization (WHO) recommended a strategy of interventions centred on primary health care and valuing the improvement of healthcare staff skills in the comprehensive management of SCD.5 Staff training is one of the cornerstones of the fight against SCD. Activities for management of patients with sickle-cell disease should be based at the primary health care level, with emphasis on programmes that use simple, affordable technology and reach a large proportion of the community, and the personnel involved in medical care will most likely be primary healthcare practitioners with task-oriented basic training in sickle-cell disease.2

This study was done in the Democratic Republic of the Congo (DRC), a country with a sickle cell trait AS prevalence of 20% – 30% and a birth rate of 2% of homozygotes.6 The state of SCD control is similar to that in Nigeria.7 In Kinshasa, a review of data from Makala Referral Hospital, located in Selembao health zone, from 2009 to 2013, noted that sickle cell anaemia was not mentioned in any of the referral notes for children with polytransfusion.8 However, given the different causes of anaemia in children and its prevalence in the DRC, one would expect SCD to be suspected in all polytransfused children.9,10 The study hypothesised that the lack of suspicion of SCD reflected a lack of knowledge of the disease.

Studies carried out in East and West Africa have revealed a low level of knowledge of the disease among the general population, medical students and some healthcare providers (HCPs).11,12,13,14 There are also deficits in various organisational aspects of the control, screening, management and treatment of sickle-cell anaemia, involving several HCPs.15,16

The Democratic Republic of the Congo in accordance with the recommendation of the WHO, being a country with a high prevalence of SCD, has set up a national programme to fight against SCD. The vision of this programme is to guarantee access to prevention and treatment services for SCD.5,17 No studies on the level of knowledge and practice of HCPs about SCD have been done in DRC. The lack of knowledge and practices would delay the interventions of the HCPs, and consequently the mortality linked to this disease in children under five would still be high. This study aimed to assess the level of knowledge and practices of SCD and to identify determinants of better practice among primary HCPs in Selembao health zone, Kinshasa, DRC.

Research methods and design

Study design

This was a cross-sectional study among HCPs in Selembao health Zone, in Kinshasa, DRC.

Study setting

Selembao health zone is one of 35 health zones in the provincial health division of the city-province of Kinshasa in the DRC.8 Selembao health zone covers a population of 478 094 inhabitants in 18 health areas. A health area is a delimited geographical entity, composed of a group of villages in rural areas of villages in rural areas and/or streets in urban areas, established according to socio-demographic affinities, with an average population size of 10 000. The average population served is 10 000, depending on the area (rural or urban).8

Each health area is covered by a referral health centre. The zone includes a referral hospital, 18 referral health centres and 140 health centres. The health zone is managed by a management team coordinated by the head of the health zone. The health centres are mainly managed by the nurses while the physicians are working in the referral hospital.

Study population

The authors recruited HCPs working in the health centres of Selembao health zone. There are three categories of nurses according to their educational level – A2: high school level nurses (4 years in secondary school), A1: graduate level nurses (3 years in college) and A0: university level (2 years post college).

Sampling size estimation

All the physicians working in the health centres were included in the study. For nurses, the minimum size was calculated using OpenEpi software.18 Considering the total number of nurses in the health centres (790), an estimated frequency of knowledge about diagnosis and management of 31%,19 at a 95% confidence interval and the design effect of 1 (simple random sample); the minimum sample size was 233. Nurses were selected by simple random sampling at the facility level, with each facility required to give at least two nurses. A total of 80 physicians and 790 nurses were identified in the health centres of the zone.

Inclusion and exclusion criteria

All HCPs (physicians and nurses) performing consultations in the health centres were eligible for the study. Physicians and nurses specifically assigned to administration services were excluded.

Sampling procedure

The sampling process was different for physicians and nurses. All the physicians working in the health centres were invited to participate in the study. For the nurses, a two-stage sampling procedure was used. At the first stage, all the health centres of the health zone have been listed and assigned numbers. Then, a simple random sampling using a random number generator was performed. A total of 112 out of 158 facilities were selected. At the second stage, for the selection of HCPs, the nurses were selected also using simple random sampling. All the nurses performing consultations in the selected facilities have been listed and assigned numbers. A random number generator was used to identify the individuals to include in the study.

Data collection

Data were collected using a questionnaire adapted from a study by Adewoyin et al.12 The tool used in the current study had 92 items, divided into five sections: socio-demographic data of the HCPs (3 items), knowledge related to epidemiological data on SCD (9 items), knowledge related to clinical manifestations of SCD (15 items), knowledge related to SCD diagnosis and management (20 items) and practice of SCD diagnosis, crisis management and outpatient follow-up in a health centre (45 items). The data was collected from 15 December 2017 to March 2018.

Data analysis

After the survey, the data were entered into an Excel file and exported into SPSS v. 20 software for analysis. For each item, the participant was given a score of 1 for a correct answer and 0 for a wrong answer. The total number of correct answers obtained was divided by the total number of items per section to determine the percentage.

Categorisation of the level of knowledge considered the percentage of the total points obtained and the profession for physicians: high level (˃75%), average level (50% – 75%) and low level (˂50%); for nurses: high level (˃65%), average level (50% – 65%) and low level (<50%). For the practice, the authors used the same thresholds and categorised it as better, good and poor practice. The authors determined absolute and relative frequencies of categorical variables, means and standard deviation for continuous normal variables or medians and interquartile range for non-normal variables. Multiple linear regression was performed, separately for nurses and physicians, to identify predictors of better practices. The level of statistical significance is p < 0.05.

Ethical considerations

The study was conducted with the approval of the Ethics and Research Committee of the Protestant University of Congo (Ref N°: CEUPC 0043). Permission to carry out the study was obtained from the Provincial Health District of the city or province of Kinshasa and then approved by the Head of Selembao HZ. Written informed consent was obtained by signature of each participant after explaining the purpose and objectives of the study. Each participant was free to withdraw from the study at any stage without any negative consequences to his or her work. The participants’ responses were analysed as pooled data, and anonymity of the HCPs in the study and confidentiality of their data were always guaranteed.

Results

A total of 318 HCPs, which included 80 (25.2%) physicians and 238 (74.8%) nurses, took part in the study. Nurses were divided into 118 (49.6%) with high school level (A2), 110 (46.2%) with graduate level (A1) and 10 (4.2%) university level (A0).

Table 1 summarises the socio-demographic characteristics of participants. The mean age of the HCPs, all categories combined, was 37.8 (±9.9) years, with almost half of the HCPs (43.4%) in the 30–39 age group. Males predominated (65.1%) and most of them (31.8%) had more than 10 years of work experience.

TABLE 1.

Age, sex and experience of healthcare providers working in Selembao health zone.

Variables Nurses
Physicians (N = 80)
All (N = 318)
A2 (N = 118)
A1 (N = 110)
A0 (N = 10)
n % n %
n % n % n %
Age (years)
< 30 18 15.3 33 30.0 0 0.0 5 6.3 56 17.6
30–39 37 31.3 50 45.5 3 30.0 48 60.1 138 43.4
40–49 44 37.2 19 17.3 5 50.0 21 26.3 89 28.0
≥ 50 19 16.1 8 7.3 2 20.0 6 7.5 35 11.0
Sex
Female 47 39.8 55 50.0 3 30.0 6 7.5 111 34.9
Male 71 60.2 55 50.0 7 70.0 74 92.5 207 65.1
Experience
Less than 3 years 20 16.9 22 20.0 0 0.0 24 30.0 66 20.8
3 to 5 years 17 14.4 38 34.5 3 30.0 27 33.8 85 26.7
6 to 10 years 22 18.6 28 25.5 1 10.0 15 18.8 66 20.8
More than 10 years 59 50.0 22 20.0 6 60.0 14 17.5 101 31.8

Physicians had an average level of knowledge about the epidemiology of SCD (65.8%); among nurses, those with a university’s degree (60.0%) and a graduate degree (59.6%) had an average level of knowledge about epidemiology (Table 2).

TABLE 2.

Distribution of knowledge on sickle cell disease epidemiology among healthcare providers working in Selembao health zone.

Variables Nurses
Physicians (N = 80)
All (N = 318)
A2 (N = 118)
A1 (N = 110)
A0 (N = 10)
n % n %
n % n % n %
Have information on sickle cell disease (SCD) 113 95.8 109 99.1 10 100.0 78 97.5 310 97.5
Continents affected by SCD (Africa, America, Asia, Europe) 0 0.0 2 1.8 0 0.0 3 3.8 5 1.6
The prevalence of the S trait in DRC is more than 10% 30 25.4 31 28.2 6 60.0 33 41.3 100 31.4
The prevalence of SS in DRC is 1% to 2% 15 18.5 16 18.0 1 10.0 17 21.8 49 19.0
Both sexes are affected 80 67.8 79 71.8 9 90.0 52 65.0 220 69.2
University course is the main source of knowledge about SCD 24 20.3 79 71.8 7 70.0 76 95.0 186 58.5
SCD is an inherited disease 101 85.6 101 91.8 9 90.0 76 95.0 287 90.3
SC gene is inherited from two parents 85 72.0 84 76.4 9 90.0 69 86.3 247 77.7
The carrier of the S-trait inherited the gene from one parent 78 66.1 89 80.9 9 90.0 70 87.5 246 77.4

DRC, Democratic Republic of the Congo.

All the HCPs showed a high level of knowledge of the clinical manifestations of SCD: 85.7%, 79.3%, 72.8% and 70.1% for physicians, university level nurses, graduate degree nurses and high school level nurses, respectively (Table 3).

TABLE 3.

Healthcare provider’s knowledge of the clinical manifestations of sickle cell disease.

Clinical manifestations Nurses
Physicians (N = 80)
All (N = 318)
A2 (N = 118)
A1 (N = 110)
A0 (N = 10)
n % n %
n % n % n %
Anaemia 111 94.1 109 99.1 10 100.0 79 98.8 309 97.2
Bone pain 109 92.4 105 95.5 10 100.0 78 97.5 302 95.0
Swelling of hand/foot 103 87.3 98 89.1 9 90.0 78 97.5 288 90.6
Repeated seizures 101 85.6 101 91.8 9 90.0 73 91.3 284 89.3
Growth and developmental delay 110 93.2 101 91.8 10 100.0 75 93.8 296 93.1
Jaundice 109 92.4 104 94.5 10 100.0 76 95.0 299 94.0
Joint pain 113 95.8 104 94.5 10 100.0 76 95.0 303 95.3
Chronic leg ulcer 49 41.5 51 46.4 7 70.0 55 68.8 162 50.9
Stroke 22 18.6 18 16.4 4 40.0 50 62.5 94 29.6
Priapism 25 21.2 23 20.9 3 30.0 63 78.8 114 35.8
Pulmonary infection 45 38.1 48 43.6 5 50.0 55 68.8 153 48.1
Bone infection 82 69.5 85 77.3 10 100.0 66 82.5 243 76.4
Frequent transfusions 112 94.9 100 90.9 10 100.0 79 98.8 301 94.7
Erythrocytes are short-lived and underlie anaemia 104 88.1 104 94.5 8 80.0 75 93.7 291 91.5
Recurrent infections may suspect SCD 45 38.1 51 46.4 4 40.0 51 63.8 151 47.5

SCD, sickle cell disease.

The proportion of high school and graduate-level nurses with an average level of knowledge about the diagnosis, and management of SCD was 52.8% and 55.9%, respectively (Table 4).

TABLE 4.

Healthcare provider’s knowledge of diagnosis and management of sickle cell disease.

Variables Nurses
Physicians (N = 80)
All (N = 318)
A2 (N = 118)
A1 (N = 110)
A0 (N = 10)
n % n %
n % n % n %
Diagnosis
diagnosis before 6 months of life 71 60.2 79 71.8 7 70.0 60 75.0 217 68.2
Blood type is not useful 36 30.5 46 41.8 5 50.0 61 76.3 148 46.5
Emmel test is used as a guide 43 36.4 52 47.3 7 70.0 58 72.5 160 50.3
Haemoglobin electrophoresis is used for confirmation 90 76.3 86 78.2 8 80.0 79 98.8 263 82.7
Rapid diagnostic test for SCD is for referral 24 20.3 30 27.3 2 20.0 34 42.5 90 28.3
Management
Treatment of acute crisis
 Abundant hydration 32 27.1 29 26.4 4 40.0 21 26.3 86 27.0
 Pain management 87 73.7 80 72.7 6 60.0 75 93.8 248 78.0
 Blood transfusion 100 84.7 94 85.5 9 90.0 75 93.8 278 87.4
 Oxygenation 69 58.5 65 59.1 7 70.0 67 83.8 208 65.4
Maintenance treatment
 Folic acid 72 61.0 64 58.2 7 70.0 64 80.0 207 65.1
 Breastfeeding can be encouraged 55 46.6 54 49.1 7 70.0 40 50.0 156 49.1
 Deworming 61 51.7 53 48.2 8 80.0 47 58.8 169 53.1
 Oral penicillin 43 36.4 32 29.1 6 60.0 42 52.5 123 38.7
 Vaccination (routine and extends to other germs) 54 45.8 62 56.4 8 80.0 58 72.5 182 57.2
 Therapeutic education about the disease and its consequences 75 63.6 74 67.3 9 90.0 66 82.5 224 70.4
 Hydration 25 3.4 27 1.8 5 50.0 24 11.3 81 25.5
 Hydroxyurea to reduce frequency of attacks 15 12.7 17 15.5 4 40.0 38 47.5 74 23.3
Prevention
 Expand community screening to adolescents 100 84.7 93 84.5 9 90.0 73 91.3 275 86.5
 Offer premarital screening 100 84.7 103 93.6 10 100.0 77 96.3 290 91.2
 Perform provider-initiated screening 96 81.4 90 81.8 9 90.0 69 86.3 264 83.0

SCD, sickle cell disease.

Table 5 details the practices of the healthcare provides on SCD: use of screening tests, description of symptoms or signs allowing to evoke the diagnosis of SCD, the performance of diagnostic tests and the management. Only physicians had good practices on SCD (50.1%); all nurses regardless of educational level had low practices with 42.6%, 44.2% and 40.7% for university level nurses, graduate level nurses and high school nurses, respectively (Table 5).

TABLE 5.

Healthcare provider’s practice related to diagnosis, crisis management and outpatient follow-up of sickle cell patients.

Variables Nurses
Physicians (N = 80)
All (N = 318)
A2 (N = 118)
A1 (N = 110)
A0 (N = 10)
n % n %
n % n % n %
Screening or diagnosis
Haemoglobin profile 52 44.1 54 49.1 9 90.0 54 67.5 169 53.1
Practitioner diagnosed at least one case of SCD 78 66.1 73 66.4 6 60.0 72 90.0 229 72.0
Symptoms or signs evoking diagnosis
Fever 60 50.8 63 57.3 4 40.0 49 61.3 176 55.3
Pain 89 75.4 83 75.5 6 60.0 76 95.0 254 79.9
Cutaneous-mucosal pallor 86 72.9 75 68.2 4 40.0 73 91.3 238 74.8
Notion of previous transfusion 82 69.5 78 70.9 5 50.0 74 92.5 239 75.2
Jaundice 87 73.7 75 68.2 6 60.0 62 77.5 230 72.3
Swelling of hands and feet in infants 69 58.5 63 57.3 4 40.0 65 81.3 201 63.2
Notion of multiple deaths in the immediate family 58 49.2 58 52.7 4 40.0 40 50.0 160 50.3
Assessment of pain
Subjective (based on patient complaint) 105 89.0 97 88.2 9 90.0 73 94.3 284 89.3
Using a scale 11 9.3 13 11.8 0 0.0 18 22.5 42 13.2
Use of usual analgesics
Empirically 62 52.5 63 57.3 5 50.0 42 52.5 172 54.1
According to WHO guidelines 56 47.5 59 53.6 5 50.0 44 55.0 164 51.6
Analgesics used
Paracetamol 57 48.3 40 36.4 5 50.0 22 27.5 124 39.0
Paracetamol and codéine 17 14.4 15 13.6 1 10.0 21 26.3 54 17.0
NSAIDs (diclofenac, ibuprofen…) 38 32.2 38 34.5 3 30.0 23 28.8 102 32.1
Tramadol 73 61.9 56 50.9 6 60.0 39 48.8 174 54.7
Morphine 1 0.8 0 0.0 0 0.0 0 0.0 1 0.3
Other treatments
Transfusion 9 7.6 14 12.7 1 10.0 12 15.0 36 11.3
Hydration with saline 12 10.2 15 13.6 2 20.0 14 17.5 43 13.5
Oxygen 35 29.7 35 31.8 4 40.0 39 48.8 113 35.5
Hydroxyurea 10 8.5 5 4.5 2 20.0 12 15.0 29 9.1
Outpatient follow-up
Provider has ever followed a SCD patient 40 33.9 38 34.5 5 50.0 32 40.0 115 36.2
SCD follow-up may be once a month 27 22.9 27 24.5 4 40.0 22 27.0 80 25.2
Laboratory tests
Haemoglobin. white blood cell count. complete blood count 103 87.3 97 88.2 8 80.0 71 88.8 279 87.7
Sedimentation rate 15 12.7 7 6.4 1 10.0 4 5.0 27 8.5
C-reactive protein 8 6.8 16 14.5 0 0.0 4 5.0 28 8.8
Lactate dehydrogenase 20 16.9 35 31.8 2 20.0 20 25.0 77 24.2
Urea and creatinine 38 32.2 19 17.3 2 20.0 53 66.3 112 35.2
Transaminases 24 20.3 34 30.9 4 40.0 41 51.3 103 32.4
Total/indirect bilirubin 38 32.2 26 23.6 4 40.0 52 65.3 120 37.7
10-reagent urine dipstick 19 16.1 44 40.0 2 20.0 21 26.3 86 27.0
Conventional radiography 37 31.4 61 55.5 4 40.0 38 47.5 140 44.0
Abdominal ultrasound 46 39.0 60 54.5 4 40.0 54 67.5 164 51.6
Cardiac ultrasound 47 39.8 30 27.3 4 40.0 45 56.3 126 39.6
Transcranial doppler ultrasound 24 20.3 46 41.8 4 40.0 29 36.3 103 32.4
Electrocardiogram 41 34.7 28 25.5 2 20.0 40 50.0 111 34.9
CT scan 34 28.8 21 19.1 1 10.0 25 33.8 81 25.5
Reason for transfer
Medical logistic and financial 80 67.5 72 65.5 7 70.0 48 60.0 207 65.1
Limited clinical skills of the centre 92 78.0 78 70.9 7 70.0 48 60.0 225 70.8
Medical reasons for referral
Pain resistant to usual analgesics 98 83.1 88 80.0 6 60.0 46 57.5 238 74.8
Persistent infection 101 85.6 100 90.9 5 50.0 53 66.3 259 81.4
Decompensated anaemia 97 82.2 92 83.6 8 80.0 67 83.8 264 83.0
Reference-counter-reference
Provider develops referral score 90 76.3 88 80.0 8 80.0 65 81.3 251 78.9
Provider receive counter-reference score 18 15.3 11 10.0 0 0.0 3 3.8 32 10.1

SCD, sickle cell disease; WHO, World Health Organizations; CT, computed tomography; NSAIDs, Non-steroidal anti-inflammatory drugs.

For physicians, multiple linear regression was used to test whether age, duration of occupation and knowledge of the disease predicted sickle cell practice. The overall regression was statistically significant (R2 = [0.3360], F[7.62] = [4.48], p = [0.0004]). It was found that SCD knowledge predicted SCD practice (ß = [0.4592492], p = [0.000]).

For nurses, multiple linear regression was used to test whether age, title, duration of occupation and knowledge of the disease predicted sickle cell practice. The overall regression was statistically significant (R2 = [0.3571], F[30.186] = [3.44], p = [0.0000]). Sickle cell disease knowledge and duration of work experience were found to predict SCD practice.

Discussion

The results of this study conducted to assess the knowledge and practices of primary HCPs on SCD showed an average level of knowledge about the diagnosis and management. Most participants were male, and a significant number had more than 10 years of work experience. The physicians showed good practice while all the nurses had a poor practice of SCD. Better practice on SCD practice was associated with knowledge among physicians and with knowledge and time in practice among nurses.

The predominance of male health care providers in the study sample highlights the existence of gender inequality within the medical workforce in the designated health zone of Kinshasa, DRC. Elsewhere, there is a tendency for female-predominant PHC organisations’ healthcare.20 It was found that women providers have a more patient-centred communication and are more likely to meet quality performance measures.21 Addressing gender disparities could enhance provision and ensure optimal patient outcomes.

The HCPs show either average level (physicians, university and graduate level nurses) or poor level of knowledge on the epidemiology of SCD. It is essential for the HCPs to have a good knowledge on the epidemiology of sickle cell disease to implement effective preventive measures and tailor interventions to the needs of the population. The average level of knowledge indicates a potential gap and underscores the need for enhanced training and educational initiatives. Another area for training would be knowledge on clinical diagnosis and management where the health providers also showed average knowledge. And the situation is not limited to Kinshasa; a study in Kindu in the Eastern part of the DRC found poorer knowledge among HCPs with 48.8% and 26.6% having awareness of Emmel test and haemoglobin electrophoresis, respectively.22 A study in Tanzania showed that only 25.1% had good knowledge on SCD.23 Encouragingly, participants demonstrated a high level of knowledge about the clinical manifestations of SCD. This is a positive indicator, as recognition of the signs and symptoms of SCD is essential for timely diagnosis and intervention.

A slightly more than half of the physicians reported having performed activities related to the diagnosis, management of crises and ambulatory follow-up of sickle cell patients. For the nurses, fewer than half the participants reported having performed these activities. Gomes and colleagues found a better practice than in the current study (65.5%), ranging from 40.4% to 87.23%.22 It is interesting to note that the authors considered physicians and nurses without distinction and addressed the knowledge of management only on children. It is noteworthy that the study by Gomes and colleagues assessed HCPs as a collective group, without distinguishing between physicians and nurses, and focused solely on the knowledge of managing paediatric populations. This may explain the observed higher level of practice, as the assessment of physicians may compensate for the potentially lower level of nurses, and the surveyed medical staff exclusively treated paediatric populations, which are likely to encounter a higher frequency of SCD cases. In contrast, the current study conducted separate assessments for nurses and physicians and included providers who were not exclusively dedicated to treating children.

This analysis using multivariate linear regression found that for physicians, there was a significant relationship between their knowledge of SCD and their practices in managing the condition. For nurses, both their knowledge of SCD and the duration of their work experience in the profession were significant predictors of their practice in managing the disease. This distinction between the predictors for physicians and nurses may be attributed to the compensatory effect of extensive professional experience for nurses, which may mitigate the impact of a lower level of academic knowledge. Essentially, nurses may enhance their understanding and management of SCD through accumulated field experience, thereby improving their practice in managing the condition.25,26 Nevertheless, for this knowledge to be translated in practice, health centres must have the necessary equipment for diagnosing SCD. A multisite study in the DRC showed that 85% of the participants, from which the most were physicians, had no access to diagnostic tools of sickle disease.26 The study in Tanzania also showed that regional-level hospitals lacked diagnostic tests and hydroxyurea.23 The findings of the current study are corroborated by studies that have linked practices on sickle cell disease with either the knowledge of the disease16 or provider qualification.24

Strengths and limitations

To the best of our knowledge, this is the first study in the sub-Saharan Africa to deal with the factors associated with better practice on SCD. The study used a detailed questionnaire to identify areas for possible improvement in terms of knowledge and practice.

However, some limitations should be considered. Firstly, the study was conducted in a specific health zone in Kinshasa, DRC, which might limit the generalisability of the findings to other regions or countries with different healthcare systems and demographics. Secondly, the reliance on self-reported data from HCPs may introduce response bias. Thirdly, because of its cross-sectional design, it is not possible to conclude on definitive relationship between factors identified for better practice on SCD.

Nonetheless, this study sheds light on the current state of knowledge and practices among HCPs in the health zone regarding SCD. Addressing the factors identified as associated with practice could enhance the quality of SCD care.

Conclusion

This study found that better practices on SCD were associated with either the level of knowledge on the disease (for all the HCPs) or with the duration of work experience for nurses. Raising the level of knowledge and improving the practices of the HCPs through continuing professional education might be beneficial in implementing opportunistic prevention of SCD in the setting. Taking into account the prevalence of SCD in the study setting, health centres must be equipped with basic equipment to ensure the diagnosis of the disease.

Acknowledgements

The authors acknowledge the Head of the Division of Health of the City-Province of Kinshasa, the Chief Medical Officer of the Selembao’s Health Zone, the teams of the Sickle Cell Disease Care Unit of the Makala General Hospital (HGR Makala), and the Medical Officer of the Sickle Cell Disease and Chronic Disease Management Unit (UPDMC).

Competing interests

The authors have declared that no competing interest exists.

Authors’ contributions

A.-C.M.N. conceived the study and conducted the study as the principal investigator. J.-P.L.F. contributed to the design of the study, analysis of the data and the writing of the first draft of the article. E.B. supervised the research work, contributed to the operationalisation of the study and edited the article. P.N.L. contributed to the design of the study, analysis of the data and the writing of the article.

Data availability

Data supporting the findings of this research will be made available from the corresponding author P.N.L. upon reasonable request.

Disclaimer

The views and opinions expressed in this article are those of the authors and are the product of professional research. It does not necessarily reflect the official policy or position of any affiliated institution, funder, agency, or that of the publisher. The authors are responsible for this article’s results, findings, and content.

Funding Statement

Funding information This research received no specific grant from any funding agency in the public, commercial or not-for-profit sectors.

Footnotes

How to cite this article: Ngonde A-CM, Fina J-PL, Burgueno E, Lukanu PN. Knowledge and practices of sickle cell disease among healthcare providers in Kinshasa, Democratic Republic of the Congo. Afr J Prm Health Care Fam Med. 2024;16(1), a3631. https://doi.org/10.4102/phcfm.v16i1.3631

References

  • 1.Ashorobi D, Ramsey A, Yarrarapu SNS, et al. Sickle cell trait. 2022. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2023. [Google Scholar]
  • 2.World Health Assembly, 59 . Fifty-ninth World Health Assembly, Geneva, 22–27 May 2006: Resolutions and decisions: Annexes [homepage on the Internet]. World Health Organization; 2006. [cited 2023 Oct 22]. Available from: https://iris.who.int/handle/10665/21481 [Google Scholar]
  • 3.Piel FB, Steinberg MH, Rees DC. Sickle cell disease. N Engl J Med. 2017;376(16):1561–1573. 10.1056/NEJMra1510865 [DOI] [PubMed] [Google Scholar]
  • 4.Makani J, Cox SE, Soka D, et al. Mortality in sickle cell anemia in Africa: A prospective cohort study in Tanzania. PLoS One. 2011;6(2):e14699. 10.1371/journal.pone.0014699 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Regional Committee for Africa, 60 . Sickle-cell disease: A strategy for the WHO African Region [homepage on the Internet]. Brazzavile: WHO; 2011. [cited 2023 Oct 22]. Available from: https://iris.who.int/handle/10665/1682 [Google Scholar]
  • 6.Tshilolo L, Aissi LM, Lukusa D, et al. Neonatal screening for sickle cell anemia in the Democratic Republic of the Congo: Experience from a pioneer project on 31 204 newborns. F J Clin Pathol. 2009;62(1):35–38. 10.1136/jcp.2008.058958 [DOI] [PubMed] [Google Scholar]
  • 7.Nnodu OE. Interventions for the prevention and control of sickle cell disease at primary health care centres in Gwagwalada Area Council of the Federal Capital Territory, Nigeria. Cureus. 2014;6(8):e194. 10.7759/cureus.194 [DOI] [Google Scholar]
  • 8.DRC Ministry of Public Health . [Compendium of standards for the organization and operation of health structures in the Democratic Republic of Congo’s health zone]. Knshasa: DRC Ministry of Public Health; 2012. [Google Scholar]
  • 9.Tawfique M, Jamal CY. Approach to diagnosis of anemia in children. North Int Med Coll J. 2017;9(1):248–251. 10.3329/nimcj.v9i1.35920 [DOI] [Google Scholar]
  • 10.Bernaudin F, Verlhac S, Coïc L, et al. Long-term follow-up of pediatric sickle cell disease patients with abnormal high velocities on transcranial Doppler. Pediatr Radiol. 2005;35(3):242–248. 10.1007/s00247-005-1419-5 [DOI] [PubMed] [Google Scholar]
  • 11.Guédéhoussou T, Gbadoé AD, Lawson-Evi K, et al. Knowledge of sickle cell disease and prevention practices in the population of an urban district of Lomé, Togo. Bull Soc Pathol Exot. 2009;102(4):247–251. [PubMed] [Google Scholar]
  • 12.Adewoyin AS, Alagbe AE, Adedokun BO, et al. Knowledge, attitude and control practices of sickle cell disease among youth corps members in Benin City, Nigeria. Ann Ib Postgrad Med. 2015;13(2):100–107. [PMC free article] [PubMed] [Google Scholar]
  • 13.Wonkam A, Njamnshi AK, Angwafo FF. Knowledge and attitudes concerning medical genetics amongst physicians and medical students in Cameroon (sub-Saharan Africa). Genet Med. 2006;8(6):331–338. 10.1097/01.gim.0000223542.97262.21 [DOI] [PubMed] [Google Scholar]
  • 14.Okwi AL, Byarugaba W, Ndugwa CM, et al. Knowledge gaps, attitude and beliefs of the communities about sickle cell disease in Eastern and Western Uganda. East Afr Med J. 2009;86(9):442–449. 10.4314/eamj.v86i9.54167 [DOI] [PubMed] [Google Scholar]
  • 15.Adegoke SA, Akinlosotu MA, Adediji OB, et al. Sickle cell disease in southwestern Nigeria: Assessment of knowledge of primary healthcare workers and available facilities. Trans R Soc Trop Med Hyg. 2018;112(2):81–87. 10.1093/trstmh/try025 [DOI] [PubMed] [Google Scholar]
  • 16.Ayugi B. Sickle cell screening among health workers in Tororo District, Uganda. Saarbrücken: Lambert Academic Publishing; 2020. [Google Scholar]
  • 17.DRC Ministry of Public Health. [National strategic plan for the fight against sickle cell disease to 2020 – 2022]. Kinshsa: DRC Ministry of Public Heatlh; 2020. [Google Scholar]
  • 18.Dean AG, Sullivan KM, Soe MM. OpenEpi: Open Source Epidemiologic Statistics for Public Health [homepage on the Internet]. [cited 2013 May 21]. Available from: https://www.openepi.com/SampleSize/SSPropor.htm
  • 19.Waters J, Thomas V. Pain from sickle-cell crisis. Nurs Times. 1995;91(16):29–31. [PubMed] [Google Scholar]
  • 20.Pineault R, Borgès Da Silva R, Provost S, et al. Do gender-predominant primary health care organizations have an impact on patient experience of care, use of services, and unmet needs? Inquiry. 2017;54:46958017709688. 10.1177/0046958017709688 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Jackson JL, Farkas A, Scholcoff C. Does provider gender affect the quality of primary care? J Gen Intern Med. 2020;35(7):2094–2098. 10.1007/s11606-020-05796-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Katawandja AL, Kingwengwe AA, Mwamba ES. Knowledge and practices of health providers on the diagnosis and biological monitoring of sickle cell disease in the city of Kindu, in the East of the Democratic Republic of Congo. Open Access Libr J. 2020;7:e6757. 10.4236/oalib.1106757 [DOI] [Google Scholar]
  • 23.Jonathan A, Tutuba H, Lloyd W, et al. Healthcare workers’ knowledge and resource availability for care of sickle cell disease in Dar es Salaam, Tanzania. Front Genet. 2022;12:773207. 10.3389/fgene.2021.773207 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Gomes LM, Vieira MM, Reis TC, et al. Knowledge of family health program practitioners in Brazil about sickle cell disease: A descriptive, cross-sectional study. BMC Fam Pract. 2011;12:89. 10.1186/1471-2296-12-89 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Diniz KKS, Pagano AS, Fernandes APPC, et al. Knowledge of professional healthcare providers about sickle cell disease: Impact of a distance education course. Hematol Transfus Cell Ther. 2019;41(1):62–68. 10.1016/j.htct.2018.06.004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Mukinayi Mbiya B, Tumba Disashi G, Gulbis B. Sickle cell disease in the Democratic Republic of Congo: Assessing physicians’ knowledge and practices. Trop Med Infect Dis. 2020;5(3):127. 10.3390/tropicalmed5030127 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

Data supporting the findings of this research will be made available from the corresponding author P.N.L. upon reasonable request.


Articles from African Journal of Primary Health Care & Family Medicine are provided here courtesy of AOSIS

RESOURCES